The human α2-plasmin inhibitor: Functional characterization of the unique plasmin(ogen)-binding region

Cellular and Molecular Life Sciences

Volumn 67, Issue 9, 2010, Pages 1505-1518

  Gerber, Simon S ^a   Lejon, Sofia ^a   Locher, Michael ^a   Schaller, Johann ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

2 Plasmin inhibitor; Fluorescence titration; Kringle; Lysine binding site; Plasminogen binding region

Indexed keywords

ALANINE; ALPHA 2 ANTIPLASMIN; LYSINE; PLASMINOGEN; RECOMBINANT PROTEIN; TYROSINE; PEPTIDE; PLASMIN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; GENE MUTATION; HUMAN; KRINGLE DOMAIN; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SULFATION; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

ESCHERICHIA COLI;

ALPHA-2-ANTIPLASMIN; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; FIBRINOLYSIN; HUMANS; KRINGLES; LYSINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMINOGEN; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT;

EID: 77952302810     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0264-3     Document Type: Article

References (66)

1. HR Lijnen B Wiman D Collen 1982 Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors Thromb Haemost 48 311 314 1:CAS:528:DyaL3sXmslyjuw%3D%3D 6984543
2. D Collen 1976 Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma Eur J Biochem 69 209 216 10.1111/j.1432-1033. 1976.tb10875.x 1:CAS:528:DyaE28XlvVygsro%3D 136345
3. 2-plasmin inhibitor from human plasma J Biol Chem 251 5956 5965 1:CAS:528:DyaE28Xlslegt7Y%3D 134998
4. S Müllertz I Clemmensen 1976 The primary inhibitor of plasmin in human plasma Biochem J 159 545 553 137718
5. B Wiman D Collen 1977 Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma Eur J Biochem 78 19 26 10.1111/j.1432-1033.1977.tb11709.x 1:CAS:528:DyaE2sXlsVOrsrk%3D 21075 (Pubitemid 8164717)
6. 2-plasmin inhibitor J Biochem 106 703 707 1:CAS:528:DyaL1MXmtFSqtL8%3D 2606916
7. 2-plasmin inhibitor by established human liver cell lines Proc Natl Acad Sci 79 5684 5687 10.1073/pnas.79.18.5684 1:CAS:528:DyaL38Xlsl2gs70%3D 6291058 (Pubitemid 13252800)
8. 2-Plasmininhibitor. Inauguraldissertation, Doctoral Dissertation, University of Bern, Switzerland
9. 2-antiplasmin Thromb Res 105 247 256 10.1016/S0049-3848(02)00020-8 1:CAS:528:DC%2BD38Xitlaltbo%3D 11927131 (Pubitemid 34260948)
10. 2-antiplasmin inhibition of fibrin digestion Blood 103 3783 3788 10.1182/blood-2003-12-4240 1:CAS:528: DC%2BD2cXjvF2iurg%3D 14751930 (Pubitemid 38596296)
11. 2- plasmin inhibitor from human plasma and culture media of Hep G2 cells Biochem Biophys Res Commun 200 417 422 10.1006/bbrc.1994.1465 1:CAS:528: DyaK2cXksFCmsLc%3D 8166714
12. 2-plasmin inhibitor deduced from the cDNA sequence J Biochem 102 1033 1041 1:CAS:528:DyaL1cXhtVOhtbo%3D 2830248
13. 2-antiplasmin, a serine protease inhibitor (serpin) J Biol Chem 262 1659 1664 1:CAS:528:DyaL2sXhslWku7k%3D 2433286
14. S Christensen Z Valnickova IB Thøgersen EH Olsen JJ Enghild 1997 Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties Biochem J 323 847 852 1:CAS:528:DyaK2sXjtFKjtLY%3D 9169621
15. 2-antiplasmin J Biol Chem 262 3082 3085 1:CAS:528:DyaL2sXhtlChurg%3D 2434496
16. 2-plasmin inhibitor J Biol Chem 261 15591 15595 1:CAS:528:DyaL28Xls12ltLs%3D 2877981
17. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis J Clin Invest 69 536 542 10.1172/JCI110479 1:CAS:528:DyaL38XhtF2qs78%3D 7199538 (Pubitemid 12184949)
18. 2-plasmin inhibitor C-terminal peptide Biochemistry 42 1078 1085 10.1021/bi026917n 1:CAS:528:DC%2BD3sXitVGjtg%3D%3D 12549929 (Pubitemid 36159542)
19. B Wiman HR Lijnen D Collen 1979 On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen Biochim Biophys Acta 579 142 154 1:CAS:528:DyaE1MXltVCnur8%3D 157166
20. T Sasaki T Morita S Iwanaga 1986 Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor J Biochem 99 1699 1705 1:CAS:528:DyaL28XksFKrtb8%3D 3745142
21. GL Hortin BL Gibson KF Fok 1988 Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin Biochem Biophys Res Commun 155 591 596 10.1016/S0006-291X(88)80535-7 1:CAS:528:DyaL1MXitVegsg%3D%3D 2458720
22. 2-antiplasmin Blood 111 2049 2052 10.1182/blood-2007-09- 114215 1:CAS:528:DC%2BD1cXisVeisb4%3D 18063751 (Pubitemid 351451516)
23. D Raum D Marcus CA Alper R Levey PD Taylor TE Starzl 1980 Synthesis of human plasminogen by the liver Science 208 1036 1037 10.1126/science.6990488 1:CAS:528:DyaL3cXktVCltbc%3D 6990488
24. H Tordai L Bányai L Patthy 1999 The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins FEBS Lett 461 63 67 10.1016/S0014-5793(99)01416-7 1:CAS:528:DyaK1MXotVClsrc%3D 10561497 (Pubitemid 29528571)
25. Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S (1978) In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis, vol 3. Raven Press, New York, pp 191-209
26. X Wang X Lin JA Loy J Tang XC Zhang 1998 Crystal structure of the catalytic domain of human plasmin complexed with streptokinase Science 281 1662 1665 10.1126/science.281.5383.1662 1:CAS:528:DyaK1cXmtVKitr0%3D 9733510 (Pubitemid 28435579)
27. CP Ponting JM Marshall SA Cederholm-Williams 1992 Plasminogen: a structural review Blood Coagul Fibrinolysis 3 605 614 10.1097/00001721- 199210000-00012 1:CAS:528:DyaK3sXlsVOhtw%3D%3D 1333289
28. U Christensen I Clemmensen 1977 Kinetic properties of the primary inhibitor of plasmin from human plasma Biochem J 163 389 391 1:CAS:528:DyaE2sXltFersrs%3D 141280
29. B Wiman D Collen 1978 On the kinetics of the reaction between human antiplasmin and plasmin Eur J Biochem 84 573 578 10.1111/j.1432-1033.1978. tb12200.x 1:CAS:528:DyaE1cXktVahtLc%3D 147769 (Pubitemid 8301289)
30. 2- antiplasmin J Biol Chem 262 6055 6059 1:CAS:528:DyaL2sXktF2ru7s%3D 2437112
31. B Wiman L Boman D Collen 1978 On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin Eur J Biochem 87 143 146 10.1111/j.1432-1033.1978.tb12360.x 1:CAS:528:DyaE1cXkvVKnsb4%3D 149657
32. B Wiman D Collen 1979 On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin J Biol Chem 254 9291 9297 1:CAS:528: DyaE1MXlvVymu7Y%3D 158022
33. C Kluft P Los AF Jie VW van Hinsbergh E Vellenga J Jespersen CP Henny 1986 The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood Blood 67 616 622 1:CAS:528:DyaL28XhsVKitb8%3D 2418896
34. I Clemmensen S Thorsen S Müllertz LC Petersen 1981 Properties of three different molecular forms of the α2plasmin inhibitor Eur J Biochem 120 105 112 10.1111/j.1432-1033.1981.tb05675.x 1:CAS:528:DyaL3MXls1Clsr8%3D 6458494
35. 2-antiplasmin Thromb Res 54 621 632 10.1016/0049-3848(89)90128-X 1:CAS:528:DyaL1MXlt12mur0%3D 2551057 (Pubitemid 19170997)
36. H Wang A Yu B Wiman S Pap 2003 Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin Eur J Biochem 270 2023 2029 10.1046/j.1432-1033.2003. 03578.x 1:CAS:528:DC%2BD3sXjslGmsLg%3D 12709062 (Pubitemid 36560824)
37. H Wang A Karlsson I Sjöström B Wiman 2006 The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance Biochim Biophys Acta 1764 1730 1734 1:CAS:528:DC%2BD28Xht1Sjs7%2FE 17064970
38. Brunisholz R, Lerch P, Rickli EE (1979) Structural comparison between human, porcine and bovine plasminogen. In: Neri Serneri GG, Prentice CRM (eds) Haemostasis and thrombosis, vol 15. Academic press, London, pp 757-761
39. R Novy D Drott K Yaeger R Mierendorf 2001 Overcoming the codon bias of E. coli for enhanced protein expression inNovations 12 1 3
40. G Qing L-C Ma A Khorchid GVT Swapna TK Mal MM Takayama B Xia S Phadtare H Ke T Acton GT Montelione M Ikura M Inouye 2004 Cold-shock induced high-yield protein production in Escherichia coli Nat Biotechnol 22 877 882 10.1038/nbt984 1:CAS:528:DC%2BD2cXlt1OksLo%3D 15195104 (Pubitemid 38886608)
41. KM Bromfield NS Quinsey PJ Duggan RN Pike 2006 Approaches to selective peptidic inhibitors of factor Xa Chem Biol Drug Des 68 11 19 10.1111/j.1747-0285.2006.00404.x 1:CAS:528:DC%2BD28XhtVOjur%2FN 16923021 (Pubitemid 44272814)
42. JP Ludeman RN Pike KM Bromfield PJ Duggan J Cianci B Le Bonniec JC Whisstock SP Bottomley 2003 Determination of the P1′, P2′ and P3′ subsite-specificity of factor Xa Int J Biochem Cell Biol 35 221 225 10.1016/S1357-2725(02)00128-0 1:CAS:528:DC%2BD38XptlCrtLk%3D 12479872 (Pubitemid 35441279)
43. H Sletta A Tøndervik S Hakvåg TE Vee Aune A Nedal R Aune G Evensen S Valla TE Ellingsen T Brautaset 2007 The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli Appl Environ Microbiol 73 906 912 10.1128/AEM.01804-06 1:CAS:528:DC%2BD2sXltlalsb4%3D 17142370 (Pubitemid 46233509)
44. 1H-NMR Biochemistry 36 11591 11604 10.1021/bi971316v 1:CAS:528:DyaK2sXlvVCmt7Y%3D 9305949 (Pubitemid 27424084)
45. D Marti J Schaller B Ochensberger E Rickli 1994 Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for ω-aminocarboxylic acids Eur J Biochem 219 455 462 10.1111/j.1432-1033.1994.tb19959.x 1:CAS:528:DyaK2cXht1Klu78%3D 8307012
46. JT Douglas PD von Haller M Gehrmann M Llinás J Schaller 2002 The two-domain NK1 fragment of plasminogen: folding, ligand binding, and thermal stability profile Biochemistry 41 3302 3310 10.1021/bi016018j 1:CAS:528:DC%2BD38Xht1eksr8%3D 11876638 (Pubitemid 34214028)
47. J-Y Chang R Knecht 1991 Direct analysis of the disulfide content of proteins: methods for monitoring the stability and refolding process of cystine-containing proteins Anal Biochem 197 52 58 10.1016/0003-2697(91)90354-V 1:CAS:528:DyaK3MXmtVagtr0%3D 1952075
48. BA Bidlingmeyer SA Cohen TL Tarvin 1984 Rapid analysis of amino acids using pre-column derivatization J Chromatogr 336 93 104 10.1016/S0378-4347(00) 85133-6 1:CAS:528:DyaL2MXkt1ehsg%3D%3D 6396315
49. N Menhart LC Sehl RF Kelley FJ Castellino 1991 Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with ω-amino acids Biochemistry 30 1948 1957 10.1021/bi00221a031 1:CAS:528:DyaK3MXnslKqsg%3D%3D 1993205
50. G Scatchard 1949 The attractions of proteins for small molecules and ions Ann N Y Acad Sci 51 660 672 10.1111/j.1749-6632.1949.tb27297.x 1:CAS:528:DyaH1MXktFGktw%3D%3D
51. 2-plasmin inhibitor, a serpin with unique structural and functional properties. Doctoral Dissertation, University of Bern, Switzerland
52. Rejante MR (1992) Proton NMR studies on the structure and ligand-binding properties of human plasminogen kringles 1 and 4. Doctoral Dissertation, Carnegie Mellon University, Pittsburgh, PA
53. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4 Biochemistry 28 1368 1376 10.1021/bi00429a064 1:CAS:528:DyaL1MXntFKntQ%3D%3D 2496756 (Pubitemid 19058714)
54. T Thewes K Constantine I-JL Byeon M Llinás 1990 Ligand interactions with the kringle 5 domain of plasminogen JBC 265 3906 3915 1:CAS:528:DyaK3cXhsFChtrs%3D
55. MC Abad RK Arni DK Grella FJ Castellino A Tulinsky JH Geiger 2002 The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin J Mol Biol 318 1009 1017 10.1016/S0022-2836(02)00211-5 1:CAS:528:DC%2BD38Xks1Krurg%3D 12054798
56. Sofian T, Horvath A, Hitchen C, Forsyth S, Coughlin P (2008) Antibody to the C-terminal extension of antiplasmin enhances fibrinolysis. In: Proceedings of the 5th international symposium on serpin biology, structure and function, serpins2008, Leuven, Belgium
57. K Arnold L Bordoli J Kopp T Schwede 2006 The SWISS-MODEL Workspace: a web-based environment for protein structure homology modelling Bioinformatics 22 195 201 10.1093/bioinformatics/bti770 1:CAS:528:DC%2BD28XovVCltw%3D%3D 16301204 (Pubitemid 43205406)
58. T Schwede J Kopp N Guex MC Peitsch 2003 SWISS-MODEL: an automated protein homology-modeling server Nucleic Acids Res 31 3381 3385 10.1093/nar/gkg520 1:CAS:528:DC%2BD3sXltVWjsLg%3D 12824332 (Pubitemid 37442164)
59. N Guex MC Peitsch 1997 SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling Electrophoresis 18 2714 2723 10.1002/elps.1150181505 1:CAS:528:DyaK1cXhvFaks70%3D 9504803 (Pubitemid 28059943)
60. L Tranqui M-H Prandini A Chapel 1979 The structure of plasminogen studied by electron Microscopy Biol Cell 34 39 42 1:CAS:528:DyaE1MXhvVagtrw%3D
61. JW Weisel C Nagaswami B Korsholm LC Petersen E Suenson 1994 Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy J Mol Biol 235 1117 1135 10.1006/jmbi.1994.1061 1:CAS:528:DyaK2cXhvVyjsLo%3D 8289311 (Pubitemid 24047845)
62. B Ho-Tin-Noé G Rojas R Vranckx HR Lijnen E Anglés-Cano 2005 Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis FEBS J 272 3387 3400 10.1111/j.1742-4658.2005.04754.x 15978044 (Pubitemid 40979309)
63. E Huet JH Cauchard A Berton A Robinet M Decarme W Hornebeck G Bellon 2004 Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5 Biochem Pharmacol 67 643 654 10.1016/j.bcp.2003.09.033 1:CAS:528:DC%2BD2cXnvVCltA%3D%3D 14757164 (Pubitemid 38125249)
64. Y Cao A Chen SS An RW Ji D Davidson M Llinás 1997 Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth J Biol Chem 272 22924 22928 10.1074/jbc.272.36.22924 1:CAS:528:DyaK2sXlvFGnt7k%3D 9278456 (Pubitemid 27386115)
65. M Gonzalez-Gronow T Kalfa CE Johnson G Gawdi SV Pizzo 2003 The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells J Biol Chem 278 27312 27318 10.1074/jbc.M303172200 1:CAS:528:DC%2BD3sXltlOjs74%3D 12736244 (Pubitemid 36876889)
66. DJ Davidson C Haskell S Majest A Kherzai DA Egan KA Walter A Schneider EF Gubbins L Solomon Z Chen R Lesniewski J Henkin 2005 Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78 Cancer Res 65 4663 4672 10.1158/0008-5472.CAN-04-3426 1:CAS:528:DC%2BD2MXks1Ohtb4%3D 15930284 (Pubitemid 40740802)